AU2003263480A1 - Oral pharmaceutical compositions of fenofibrate having high bioavailability - Google Patents

Oral pharmaceutical compositions of fenofibrate having high bioavailability

Info

Publication number
AU2003263480A1
AU2003263480A1 AU2003263480A AU2003263480A AU2003263480A1 AU 2003263480 A1 AU2003263480 A1 AU 2003263480A1 AU 2003263480 A AU2003263480 A AU 2003263480A AU 2003263480 A AU2003263480 A AU 2003263480A AU 2003263480 A1 AU2003263480 A1 AU 2003263480A1
Authority
AU
Australia
Prior art keywords
fenofibrate
pharmaceutical compositions
oral pharmaceutical
high bioavailability
bioavailability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263480A
Other versions
AU2003263480A8 (en
Inventor
Rajiv Malik
Gowri Shankar Miriyala
Ajay Kumar Singla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN961DE2002 priority Critical
Priority to IN961/DEL/2002 priority
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to PCT/IB2003/004162 priority patent/WO2004028506A1/en
Publication of AU2003263480A1 publication Critical patent/AU2003263480A1/en
Publication of AU2003263480A8 publication Critical patent/AU2003263480A8/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
AU2003263480A 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability Abandoned AU2003263480A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN961DE2002 2002-09-24
IN961/DEL/2002 2002-09-24
PCT/IB2003/004162 WO2004028506A1 (en) 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability

Publications (2)

Publication Number Publication Date
AU2003263480A1 true AU2003263480A1 (en) 2004-04-19
AU2003263480A8 AU2003263480A8 (en) 2004-04-19

Family

ID=32040231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263480A Abandoned AU2003263480A1 (en) 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability

Country Status (3)

Country Link
EP (1) EP1553928A1 (en)
AU (1) AU2003263480A1 (en)
WO (1) WO2004028506A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060817A1 (en) * 2004-12-03 2006-06-08 Abbott Laboratories Pharmaceutical compositions
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
WO2008104852A2 (en) * 2007-02-26 2008-09-04 Wockhardt Research Centre Pharmaceutical compositions comprising adsorbate of fenofibrate
EP2842547A1 (en) 2013-08-27 2015-03-04 Freund Pharmatec Ltd. Improved fenofibrate compositions
EP2878311A1 (en) 2013-11-27 2015-06-03 Freund Pharmatec Ltd. Solubility Enhancement for Hydrophobic Drugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (en) * 1980-11-19 1986-01-10 Laruelle Claude
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass The pharmaceutical composition of fenofibrate having a high bioavailability and process for its preparation
FR2783421B1 (en) * 1998-09-17 2000-11-24 Cll Pharma Process for the preparation of new galenical fenofibrate formulations, galenic formulations obtained by said process and their applications
FR2795961B1 (en) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Pharmaceutical composition containing micronized fenofibrate, a surfactant and a binding cellulose derivative and process for the preparation
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (en) * 2001-01-22 2004-03-12 Fournier Lab Sa New tablets of fenofibrate
DK1487416T3 (en) * 2002-03-26 2010-03-29 Teva Pharma Drug Microparticles

Also Published As

Publication number Publication date
WO2004028506A1 (en) 2004-04-08
EP1553928A1 (en) 2005-07-20
AU2003263480A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
EP1379229B8 (en) A jasmonate pharmaceutical composition for treatment of cancer
TWI323256B (en) Novel benzazepine derivatives and pharmaceutical compositions comprising said compounds
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
IL161559D0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
HK1083770A1 (en) Pharmaceutical co-crystal of celecoxib-nicotinamide
AU2002301259A1 (en) Simethicone solid oral dosage form
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
IL213594D0 (en) Uses of pharmaceutical compositions comprising an alkaoid3
ZA200502220B (en) Oral formulations
GB0319041D0 (en) Pharmaceutical Formulations
AU2002347741A1 (en) N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
IL158771D0 (en) Pharmaceutical compositions of adsorbates of amorphous drug
IL158493D0 (en) Pharmaceutical compositions containing venlafaxine
AU2002231970A1 (en) Mucoadhesive pharmaceutical formulations
IL157741A (en) Pharmaceutical compositions
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
AU2002310504A1 (en) Oral care compositions
AU2002311922A1 (en) Oral care compositions
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
IL162213D0 (en) Pharmaceutical compositions containing active vitamin d compounds
AU2003298094A1 (en) Medicinal arylethanolamine compounds
GB2389530B (en) Pharmaceutical compositions
IL163931A (en) Derivatives of amino-methyl substituted tetracyline compounds and pharmaceutical compositions thereof
AU2003281200A1 (en) Immunopotentiating compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase